nataliezzz

Senior Member (Voting Rights)
This is a thread to discuss the evidence on obstructive sleep-disordered breathing and orthostatic intolerance.

Sleep-disordered Breathing and Hypotension, 2001, Guilleminault et al.
In a series of 4,409 consecutive Stanford sleep clinic referrals, low resting blood pressure (<105/65 here) was present in 23% of UARS patients vs. 0.06% of OSA patients - a roughly 380-fold difference*. All 15 UARS patients with low BP who underwent tilt table testing (TTT) had orthostatic hypotension. On TTT, UARS patients with OI showed a mean decrease in systolic BP of ~27 mmHg, compared to ~7 mmHg in healthy controls, OSA patients, and normotensive UARS patients. The 30:15 R–R heart rate ratio was normal in all groups, ruling out autonomic neuropathy. Notably, UARS patients with and without OI did not differ on AHI, BMI, sleep fragmentation, daytime fatigue, and negative peak esophageal pressure (a measure of respiratory effort), leaving the determinants of the low BP/OI phenotype unclear (women made up a somewhat larger share of the UARS patients with low BP [56%] than of those with normal BP [42%]).

Notable observations included:
  • All of the UARS patients in the study had an abnormally small oral cavity based on objective measurements.
  • All of the UARS patients with low BP "complained of OI and cold peripheries." None of the patients with UARS and normal BP "admitted to these symptoms on direct questioning." (It's unclear exactly what "admitted to these symptoms" means - "faint when standing up" and "cold peripheries" were the only symptoms recorded, so it's unclear if they inquired about other symptoms associated with OI).
  • The coexistence of resting tachycardia and OH in the UARS patients with low BP who underwent TTT is suggestive of clinically significant hypovolemia.
*It's interesting (and somewhat amusing to me) that the AHI 5 cutoff (that sleep medicine has used to diagnose and treat OSA based on...nothing?) actually seems to do a good job of distinguishing two potentially distinct groups here, given that it is meaningless when it comes to other symptoms in sleep-disordered breathing patients like fatigue.

Exploring the Abnormal Modulation of the Autonomic Systems during Nasal Flow Limitation in UARS by Hilbert–Huang Transform, 2017, Lin et al.
This study used breath-by-breath heart rate variability analysis to examine autonomic nervous system responses during different types of respiratory cycles in 49 UARS patients and 9 controls. It found that in UARS patients, abnormal parasympathetic responses occurred specifically during flow-limited breaths with increased respiratory effort rather than during flow limitation alone -- pointing to negative intrathoracic pressure as a key variable and ANP-mediated hypovolemia and baroreflex downward resetting as candidate downstream mechanisms.

The Guilleminault et al. (2001) study discussed above found similar negative peak esophageal pressure (measure of respiratory effort) values in UARS patients with and without OI, though patients may have identical peak pressures but differ significantly in % breaths with flow limitation with increased respiratory effort (Lin et al.'s FL[+] category). Whether total FL(+) burden differs between UARS patients with and without OI has not been tested. Individual variation in ANP responsiveness, baroreflex sensitivity, and the counter-regulatory renin-angiotensin-aldosterone system may also determine the threshold at which these effects become symptomatic.

Limitations include: the control group was small (9 controls vs. 49 UARS patients) and had better sleep architecture (including more slow-wave/deep sleep) which could independently influence the heart rate variability measures. The classification threshold for increased effort was acknowledged by the authors as somewhat arbitrary.

Obstructive Sleep Apnea and Orthostatic Hypotension: An Unconventional Association, 2025, Cobb et al.
In this case report, a 61 y/o male with OSA presented to the ED with progressively worsening low BP (systolic BP as low as 80s) as well as dizziness upon standing. Symptoms started 3 weeks after he developed difficulty using his CPAP due to improper fit of a new mask. IV fluids did not improve his symptoms. Once he was loaned a CPAP, his symptoms improved, he was discharged shortly thereafter, and symptoms did not recur since the appropriate adjustments were made to his home device. He had a complex medical history in addition to OSA (mild traumatic brain injury, pulmonary embolism, paroxysmal atrial fibrillation s/p ablation and hypothyroidism) but the changes in his BP and OI symptoms in response to stopping and reinstating CPAP seems pretty clear cut and noteworthy, even if other medical factors may be contributing in this particular case.

How it might fit in with Dr. Gold's framework

The studies above leave a mechanistic puzzle: why only some UARS patients develop OI, given that the measures available so far — negative peak esophageal pressure, AHI, sleep fragmentation — don't distinguish them from UARS patients who don't. Whether more granular measures of effortful IFL burden would explain the split remains an open question, and individual variation in ANP responsiveness, baroreflex sensitivity, and the counter-regulatory renin-angiotensin-aldosterone system may also play a role. Dr. Gold's framework offers a further speculative but anatomically grounded account. In his model, if a prior stressor has sensitized limbic circuits, the brain may shift from interpreting effortful IFL as background physiology to a recurrent threat signal, potentially reorganizing how the brainstem integrates respiratory and baroreceptor afferent input and autonomic output and predisposing susceptible individuals toward the low-BP/OI phenotype.

The anatomical scaffolding for this kind of top-down influence exists: the central amygdala and related limbic structures project directly to brainstem cardiovascular control centers, including the nucleus tractus solitarius — which is also the primary relay for baroreceptor and respiratory afferents. Whether limbic sensitization actually reshapes autonomic set-points in UARS patients is an open question; no study has tested this directly. It should be read as a speculative explanatory frame, not an established mechanism.

Alternative accounts remain equally viable: baroreflex resetting through purely mechanical pathways, ANP dysregulation independent of limbic involvement, mast cell-mediated vasodilation, or some combination. These are not mutually exclusive with Gold's framework, and it is possible that different subsets of patients reach the orthostatic phenotype by different routes.

(Note: this last section was written with the assistance of AI)
 
Last edited:
I've documented my improvements in orthostatic intolerance on BiPAP here (includes pre-BiPAP and on-BiPAP tilt table tests).

Of note, my OI started out with more purely OH-type symptoms (lightheadedness/losing vision on standing) early on and I developed more (hyper) POTS-type symptoms over time. I’ve had both OH and POTS on NASA lean tests (even within short time frames - e.g. one time I had hyperPOTS one day when I had overexerted and had the “running on adrenaline” feeling and OH the next day in PEM).
  • Dysautonomia/OI
    • Was able to stop bupropion which was previously controlling acute symptoms (lightheadedness/losing vision) on standing without return of those symptoms (took bupropion for 8 years)
    • I still get tachycardia on exertion and have remained on beta blockers (metoprolol tartrate)
    • No longer meet POTS criteria on tilt table test
      • Test #1 = pre-BiPAP. My HR was artificially elevated right before they tilted me up (I remember the tech and I were talking; you can see my other resting HR readings were in high 70s - low 80s), but even so I still met criteria for POTS (specifically, hyperadrenergic POTS)
      • Test #2 = 11 months on BiPAP; "borderline exaggerated orthostatic tachycardia: 26 bpm increase" noted
      • Beta blockers withheld starting evening before both (afternoon) tests
      • Bupropion stopped 1 week before test #1 (no longer taking for test #2)
1769055203538.png
1769055233363.png
 
Last edited:
Back
Top Bottom